San Luis Obispo, CA1 Active Studies

Pulmonary Embolism Clinical Trials in San Luis Obispo, CA

Find 1 actively recruiting pulmonary embolism clinical trials in San Luis Obispo, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
60
Enrolling

Recruiting Pulmonary Embolism Studies in San Luis Obispo

About Pulmonary Embolism Clinical Trials in San Luis Obispo

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 1 pulmonary embolism clinical trials recruiting participants in San Luis Obispo, CA. These studies are seeking a combined 60 participants. Research is being sponsored by California Polytechnic State University-San Luis Obispo. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in San Luis Obispo — FAQ

Are there pulmonary embolism clinical trials in San Luis Obispo?

Yes, there are 1 pulmonary embolism clinical trials currently recruiting in San Luis Obispo, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Luis Obispo?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Luis Obispo research site will contact you about next steps.

Are clinical trials in San Luis Obispo free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Luis Obispo studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 1 active trials in San Luis Obispo are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov